SCHEMBL4199622

SCHEMBL4199622

Cc1cc(OCC(=O)O)c(C)c(C)c1NC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
PTPRB P23467 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LCK P06239 4/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.37
CYP2C19 P33261 1/20 0.37
PTGER2 P43116 1/20 0.36
ATR Q13535 1/20 0.36
ELANE P08246 1/20 0.36
CD69 Q07108 1/20 0.36
PPARG P37231 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NLRP3 Q96P20 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5215289 0.82 ATR (0.37) HPGDPTPRBHSD17B10PTGDR2ATR
SCHEMBL3606323 0.82 ALDH1A1 (0.42) HSD17B10LCKATRCA12CA1
SCHEMBL5216310 0.81 ATR (0.36) HPGDPTPRBHSD17B10PTGDR2ATR
SCHEMBL3047823 0.80 VDR (0.40) HPGDLCKATRPPARGTP53
SCHEMBL13513557 0.80 VDR (0.40) HPGDLCKATRPPARGTP53
SCHEMBL6135907 0.80 VDR (0.40) HPGDLCKATRPPARGTP53
SCHEMBL4212562 0.80 LCK (0.39) HSD17B10LCKATRPPARGCA12
SCHEMBL6067779 0.80 ATR (0.36) HPGDPTPRBHSD17B10PTGDR2ATR
SCHEMBL4537095 0.79 TSHR (0.42) HPGDHSD17B10LCKATRPPARG
SCHEMBL4216781 0.78 LCK (0.39) HPGDPTPRBHSD17B10LCKPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488738-B2 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2009-02-10 US disclosed
EP-1228367-B1 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF ASUBIO PHARMA CO LTD (JP) 2007-09-26 EP disclosed
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. 2006-08-10 US disclosed
US-7067533-B2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. (JP) 2006-06-27 US disclosed
US-20060094737-A1 Novel uracil derivatives and medicinal use thereof SUMITOMO PHARMACEUTICALS CO. LTD. (JP) 2006-05-04 US disclosed
US-6998401-B2 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof SUNTORY LIMITED (JP) 2006-02-14 US disclosed
US-20050245574-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-11-03 US disclosed
EP-1541562-A1 NOVEL URACIL DERIVATIVES AND MEDICINAL USE THEREOF SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-06-15 EP disclosed
EP-1045693-B1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS DAIICHI SUNTORY PHARMA CO LTD (JP) 2004-06-30 EP disclosed
US-20040063748-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2004-04-01 US disclosed
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2003-07-24 US disclosed
US-6559146-B1 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins SUNTORY LIMITED (JP) 2003-05-06 US disclosed
EP-1228367-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2002-08-07 EP disclosed
WO-2001079170-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2001-10-25 WO disclosed
EP-1045693-A1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS SUNTORY LIMITED (JP) 2000-10-25 EP disclosed
WO-2000023076-A1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS SUNTORY LIMITED (JP) 2000-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094737-A1 Novel uracil derivatives and medicinal use thereof HRH3, HRH4, HRH2 HPGD 830/4885PTPRB 4750/4885HSD17B10 1914/4885
US-20050245574-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof CAMK2A, CAMK2B, SLC1A2 HPGD 3258/4885PTPRB 1210/4885HSD17B10 2276/4885
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SCN10A, CAMK2A, CAMK2B HPGD 1611/4885PTPRB 1196/4885HSD17B10 2044/4885
US-20040063748-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof FABP7, SLC1A2, CAMK2A HPGD 3594/4885PTPRB 783/4885HSD17B10 2808/4885
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof NR0B1, NR0B2, NR4A1 HPGD 1231/4885PTPRB 2478/4885HSD17B10 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.